等待开盘 09-30 09:30:00 美东时间
-4.550
-1.29%
美股上市公司儒博实业(ROP)披露一笔内部人股票交易。文件显示,公司内部人Archambeau (Shellye L)(Director)2026-09-15增...
09-19 07:02
今日重点评级关注:HC Wainwright & Co.:维持Tango Therapeutics"买入"评级,目标价从66美元升至68美元;康托·菲茨杰拉德:维持Duos Technologies Group"超配"评级,目标价从26美元升至27美元
08-19 08:37
RBC Capital analyst Deane Dray reiterates Roper Technologies (NASDAQ:ROP) with a Sector Perform and maintains $417 price target.
08-18 21:01
<p>In July 2026, contract rates for dry van and refrigerated truckload freight saw their largest June-to-July increases on record, according to DAT Freight & Analytics. Despite declining freight volumes across all equipment types, contract rates rose significantly: dry van rates increased by 13 cents per mile, reefer rates by 9 cents, and flatbed rates by 4 cents. The DAT Truckload Volume Index (TVI) showed declines for dry van, reefer, and flatb...
08-11 15:35
今日重点评级关注:康托·菲茨杰拉德:维持EyePoint"超配"评级,目标价从47美元升至55美元;伯恩斯坦:维持Figure Technology"跑赢大市"评级,目标价从67美元升至70美元
08-07 13:41
Argus Research analyst John Eade upgrades Roper Technologies (NASDAQ:ROP) from Hold to Buy and announces $450 price target.
08-07 00:12
华盛资讯8月1日讯,儒博实业公布2026财年Q2业绩,公司Q2营收21.09亿美元,同比增长8.5%,归母净利润11.69亿美元,同比增长208.9%。
08-01 05:40
Stride Inc. announced the appointment of Robert Knowling as CEO, replacing James Rhyu, and Steven Fink as Board Chair. Brian Shepherd joined the Board. The company reported strong financial results for FY 2026, including $2.518 billion in revenue and $617.6 million in adjusted EBITDA.
07-30 12:00
今日重点评级关注:古根海姆:维持ProMIS Neurosciences"买入"评级,目标价从35美元升至69美元;BTIG:维持Cullinan Therapeutics"买入"评级,目标价从38美元升至39美元
07-30 11:45
今日重点评级关注:HC Wainwright & Co.:维持居里"买入"评级,目标价从17美元升至43美元;花旗:维持Klaviyo"买入"评级,目标价从31美元升至34美元
07-27 14:02